Parkinson's disease
The company's FDA-cleared wearable uses personalized nerve stimulation to treat essential tremor and Parkinson's disease.
Dave Rosa, president and CEO of NeuroOne, joins MobihealthNews for Part 2 of the Emerging Technologies series to discuss the company's thin-film electrode technology.
PKG Health's movement disorder algorithms and digital endpoints will be integrated into Empatica’s AI-enabled health monitoring wearables.
The platform assesses cognitive and motor function via at-home assessments that generate digital biomarkers and a predictive score, supporting the early detection of Parkinson's.
The system may now be used to target patients' internal globus pallidus, a portion of the brain associated with Parkinson's disease symptoms.
The technology was co-created by researchers at MIT Media Lab and Massachusetts General Hospital Sports Science Lab.
Also: New funding rounds for Enlitic, Diameter Health and Candid.
The Belgian pharma company worked with Verint Systems to create the PD Coach app.